(1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate

DRUG INTERMEDIATES

Product Details

CAT No.# CS-T-47699
Category Drug Intermediates
CAS 229177-52-0
Molecular Weight 263.24
Molecular Formula C10H17NO7
Stock Status: In-Stock
Purity: >98%
Melting Point: 125-127
Solubility: DMSO, Methanol
Appearance: White Solid
Synonyms: (1S-cis)-4-Amino-2-cyclopentene-1-methanol D-Tartrate; (1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol (2S,3S)-2,3-Dihydroxybutanedioate;
Application Notes: (1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol is an Abacavir intermediate; antiviral therapeutic nucleoside analog.
References: Clapper, D., et al.: J. Biol. Chem., 262, 9561 (1987), Zhang, F., et al.: Bioorg. Med. Chem., 7, 653 (1999), Shuto, S., et al.: J. Med. Chem., 46, 4741 (2003), Shuto, S., et al.: Curr. Med. Chem., 11, 827 (2004),
Storage: For long term store at -20°C
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline


Smileys:
O[C@H](C(O)=O)[C@H](O)C(O)=O.OC[C@H]1C[C@@H](N)C=C1



This page contains information about (1S,4R)-cis-4-Amino-2-cyclopentene-1-methanol D-Tartrate Cas 229177-52-0 and its Drug Intermediates.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."